Clinical Trial Update: Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy [Phase 1, Phase 2]

View source ↗

Summary

A randomized Phase 1/2 trial evaluated intravenous infusion of umbilical cord mesenchymal stem cells for dilated cardiomyopathy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Dilated Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED